Asari Ekpenyong
4PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.Nabil F Saba, Ritu Chaudhary, Kedar Kirtane
|Jul 02, 2024
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.Nabil F Saba, Conor E Steuer, Asari Ekpenyong
|Feb 23, 2024
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.Fanghui Chen, Chris Tang, Fan Yang
|Apr 03, 2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.Nabil F Saba, Conor E Steuer, Asari Ekpenyong
Pageof 1
Frequent Collaborators
4 joint publications
Nabil F Saba
3 joint publications
Ashley McCook-Veal
3 joint publications
Nicole C Schmitt
3 joint publications
William Stokes
3 joint publications
Mark W McDonald
3 joint publications
Christine H Chung
2 joint publications
Yong Teng
1 joint publications
Fanghui Chen
1 joint publications
Fan Yang
1 joint publications
Jin Xie
